Welcome to LookChem.com Sign In|Join Free

CAS

  • or

73465-46-0

Post Buying Request

73465-46-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73465-46-0 Usage

Description

(3beta,17Z)-pregna-5,17-diene-3,20-diyl diacetate is a synthetic steroid derivative with the molecular formula C24H32O4. It is a diacetate ester of (3beta,17Z)-pregna-5,17-diene-3,20-diol and belongs to the class of pregnadienes. This chemical compound exhibits a variety of biological activities and is commonly used as a starting material for the synthesis of other steroid derivatives in pharmaceutical research and drug development. Its structural and functional versatility makes it a promising candidate for the development of new and improved pharmaceutical agents.

Uses

Used in Pharmaceutical Research and Drug Development:
(3beta,17Z)-pregna-5,17-diene-3,20-diyl diacetate is used as a starting material for the synthesis of other steroid derivatives. Its structural and functional versatility allows for the development of new and improved pharmaceutical agents with potential applications in various therapeutic areas.
Used in Steroid Synthesis:
(3beta,17Z)-pregna-5,17-diene-3,20-diyl diacetate is used as a key intermediate in the synthesis of various steroidal compounds. Its unique structure enables the production of a wide range of steroidal drugs with diverse therapeutic properties.
Used in Hormone Therapy:
(3beta,17Z)-pregna-5,17-diene-3,20-diyl diacetate, due to its steroidal nature, can be used in hormone therapy for the treatment of various endocrine disorders. Its potential applications include the management of conditions such as Addison's disease, congenital adrenal hyperplasia, and certain types of infertility.
Used in Anti-inflammatory and Immunosuppressive Therapies:
Given its steroidal properties, (3beta,17Z)-pregna-5,17-diene-3,20-diyl diacetate may also be utilized in the development of anti-inflammatory and immunosuppressive drugs. These agents can be used to treat a variety of inflammatory and autoimmune conditions, such as rheumatoid arthritis, lupus, and inflammatory bowel disease.
Used in Contraceptive Development:
(3beta,17Z)-pregna-5,17-diene-3,20-diyl diacetate, as a steroid derivative, can be employed in the development of contraceptive agents. Its potential use in this area could contribute to the creation of new hormonal contraceptives with improved safety and efficacy profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 73465-46-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,4,6 and 5 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 73465-46:
(7*7)+(6*3)+(5*4)+(4*6)+(3*5)+(2*4)+(1*6)=140
140 % 10 = 0
So 73465-46-0 is a valid CAS Registry Number.

73465-46-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name [(3S,8R,9S,10R,13S,14S,17E)-17-(1-acetyloxyethylidene)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73465-46-0 SDS

73465-46-0Upstream product

73465-46-0Relevant articles and documents

3BéTA-(BENZYLOXY)-17ALPHA-METHYL-PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS

-

Paragraph 0088-0089, (2020/07/07)

The present invention generally relates to a specific pregnenolone derivative for its use for the treatment of a cognitive disorders. More particularly, the invention relates to a compound of Formula (I) for its use in the treatment of cognitive disorders. Indeed, the compound of the invention is in vivo very potent in correcting the cognitive impairments observed in cognitive disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 73465-46-0